Oruen is the leading CNS medical publication and multimedia platform
Committed to improving international communication and medical education for physicians with clinical interests in CNS medicine.
This roundtable discussion was supported by Neuraxpharm MODERATOR: PROF. ALEXIS ARZIMANOGLOU...
This webinar was supported by Neuraxpharm In this webinar, our panel of expert speakers discussed...
This interview discusses anticoagulant reversal strategies in ICH and the current challenges...
This series of interviews provides the latest updates on SESAME, SOFIA EPI, and ERIC for distal,...
This video was funded by Abbvie. All content was designed and delivered by Oruen. AbbVie has...
This interview was supported by an independent educational grant by Bial Explore the cutting-edge...
Exploring cutting-edge neurointerventional tech at #ESMINT2023 with Prof. Dr. Markus Möhlenbruch....
We’re honoured to share our latest video: Patients’ testimonials, Stroke Management...
Time flies when you’re passionate about making a difference, it’s been an amazing...
This interview was supported by an independent educational grant by Bial Explore the cutting-edge...
Exploring cutting-edge neurointerventional tech at #ESMINT2023 with Prof. Dr. Markus Möhlenbruch....
We’re honoured to share our latest video: Patients’ testimonials, Stroke Management...
Time flies when you’re passionate about making a difference, it’s been an amazing...
Speakers include: Mihir Vyas Lucio D’Anna ...
First Presentation: A Challenging Case – Marta Rubiera, Hospital Vall d’Hebron,...
Full symposium – speakers in order: Prof. Joan Montaner, Dr Kiruba Nagaratnam, Dr Manu...
Friday, 26 May, 10:00 – 10:30 CEST Speakers include: Thorsten Steiner (Frankfurt, Germany), ...
Thursday, 25 May, 11:00 – 11:30 CEST Mobile stroke units have had a massive impact in...
Latest News
Alzheimer Europe calls for dementia to be a priority for European decision-makers
Alzheimer Europe regrets that negative European Medicines Agency opinion on lecanemab may deprive Europeans with Alzheimer’s disease from medicines available in the US and elsewhere
• The Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency today issued a negative opinion on the marketing authorisation application of Eisai for lecanemab for the treatment of early Alzheimer’s disease. • Lecanemab has already been...
Featured Articles
Updates from Industry Satellite Symposium, 16th May 2024, in Basel, Switzerland: 10th European Stroke Organisation Conference (ESOC)
Jonathan Coutinho, Fredrik Ståhl, Johan Wassélius
Meeting summary These presentations were sponsored by Siemens Healthineers as part of the 10th …
Current Topics Presented at the International Scientific Board of Experts on ADHD (ISBEA)
These presentations took place as part of the 8th Meeting of the International Scientific Board of Experts on ADHD (ISBEA) held on 21 September 2023 in Montpellier, France
CME
Journals
Contact Us
Follow Us
Newsletter
Keep up to date with our latest
articles and journals
Media Partners
Brain Conference
World Stroke Organization
Epilepsy Sparks
European Sleep Research Society
Migraine Trust
European Association of Neurosurgical Societies
Dystonia Europe
European Society of Radiology
National Multiple Sclerosis Society
International Society for Affective Disorders
Federation of European Neuroscience Societies
World Federation for NeuroRehabilitation
European Multiple Sclerosis Platform
European Stroke Organisation
European Society for Biomedical Research on Alcoholism
International Parkinson and Movement Disorder Society
Stroke Alliance for Europe
European Society of Minimally Invasive Neurological Therapy
European Psychiatric Association
European College of Neuropsychopharmacology
Parkinson's Europe
Stroke Association
